A Swedish-Norwegian project for the diagnosis and treatment of non-seminomatous testicular cancer. Fosså SD. Tidsskr Nor Laegeforen. 1982 Feb 28;102(6):371-4.

 

Computed tomography in early stages of testicular carcinoma. Size of normal retroperitoneal lymph nodes and lymph nodes in patients with metastases in stage II A. A SWENOTECA study: Swedish-Norwegian Testicular Cancer Project.

Forsberg L, Dale L, Høiem L, Magnusson A, Mikulowski P, Olsson AM, Ous S, Stenwig AE. Acta Radiol Diagn (Stockh). 1986 Sep-Oct;27(5):569-74.

Risk indicators in stage I testicular teratoma. Klepp O. Lancet. 1989 Mar 4;1(8636):506.

 

Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.

Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin-Ståhl E, Fosså SD, Wahlqvist L. J Clin Oncol. 1990 Mar;8(3):509-18.

 

Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).

Klepp O, Flodgren P, Maartman-Moe H, Lindholm CE, Unsgaard B, Teigum H, Fosså SD, Paus E. Ann Oncol. 1990 Jul;1(4):281-8.

 

Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.

Klepp O, Olsson AM, Ous S, Nilsson S, Høisaether PA, Tveter K. Scand J Urol Nephrol. 1991;25(3):179-90.

 

Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.

Aass N, Klepp O, Cavallin-Stahl E, Dahl O, Wicklund H, Unsgaard B, Baldetorp L, Ahlström S, Fosså SD. J Clin Oncol. 1991 May;9(5):818-26.

 

Testicular cancer--Norway among the countries with the highest frequency. Regional multicenter cooperation is effective.

Klepp O. Tidsskr Nor Laegeforen. 1995 May 30;115(14):1713-4.

 

Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer.

Klepp O, Dahl O, Flodgren P, Stierner U, Olsson AM, Oldbring J, Nilsson S, Daehlin L, Tørnblom M, Småland R, Starkhammar H, Abramsson L, Wist E, Raabe N, Edekling T, Cavallin-Ståhl E. Eur J Cancer. 1997 Jun;33(7):1038-44.

 

Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.

Kildahl-Andersen A, Erke MG, Sagstuen H, Bremnes RM. Acta Oncol. 2005;44(6):537-44.

 

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. Eur Urol. 2008 Mar;53(3):478-96. Epub 2007 Dec 26.

 

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz-Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. Eur Urol. 2008 Mar;53(3):497-513. Epub 2007 Dec 26.

 

Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.

Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, Langberg C, Bremnes RM, Laurell A, Wijkstrøm H, Klepp O. J Clin Oncol. 2009 May 1;27(13):2122-8. Epub 2009 Mar 23.

 

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Tandstad T, Cohn-Cedermark G, Dahl O, Stierner U, Cavallin-Stahl E, Bremnes RM, Klepp O. Ann Oncol. 2010 Sep;21(9):1858-63. Epub 2010 Feb 8.

 

'A no means no'--measuring depression using a single-item question versus Hospital Anxiety and Depression Scale (HADS-D). 

Skoogh J, Ylitalo N, Larsson Omeróv P, Hauksdóttir A, Nyberg U, Wilderäng U, Johansson B, Gatz M, Steineck G; Swedish-Norwegian Testicular Cancer Group. Ann Oncol. 2010 Sep;21(9):1905-9. Epub 2010 Mar 15.

 

Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors.

Skoogh J, Steineck G, Cavallin-Ståhl E, Wilderäng U, Håkansson UK, Johansson B, Stierner U; on behalf of SWENOTECA. Int J Androl. 2011 Apr 7. 

 

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G. J Clin Oncol. 2011 Feb 20;29(6):719-25. Epub 2011 Jan 4.

 

A population-based study of treatment guided by tumor marker decline in 603 patients with metastatic non-seminomatous germ cell tumor - A report from the Swedish-Norwegian Testicular Cancer Group (SWENOTECA).

Olofsson SE, Tandstad T, Jerkeman M, Dahl O , Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark C, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E. J Clin Oncol 2011 May.

 

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G. J Clin Oncol 2011 Feb.

 

High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).

Haugnes HS, Laurell A, Stierner U, Bremnes RM, Dahl O, Cavallin-Ståhl E, Cohn-Cedermark G.Acta Oncol 2012 Feb.

 

Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. 

Skoogh J, Steineck G, Stierner U, Cavallin-Ståhl E, Wilderäng U, Wallin A, Gatz M, Johansson B; Swenoteca.Acta Oncol 2012 Feb.

 

”Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.”

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S, Giwercman A, Hartmann JT, Heidenreich A, Hentrich M, Honecker F, Horwich A, Huddart RA, Kliesch S, Kollmannsberger C, Krege S, Laguna MP, Looijenga LH, Lorch A, Lotz JP, Mayer F, Necchi A, Nicolai N, Nuver J, Oechsle K, Oldenburg J, Oosterhuis JW, Powles T, Rajpert-De Meyts E, Rick O, Rosti G, Salvioni R, Schrader M, Schweyer S, Sedlmayer F, Sohaib A, Souchon R, Tandstad T, Winter C, Wittekind C.

Ann Oncol. 2013 Apr;24(4):878-88. Epub 2012 Nov 14.

 

Psychological needs when diagnosed with testicular cancer: findings from a population-based study with long-term follow-up.

Skoogh J, Steineck G, Johansson B, Wilderäng U, Stierner U; SWENOTECA. BJU Int 2013 Jun.

 

One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.

Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G; on behalf of SWENOTECA. Ann Onc 2014 Aug 11.

 

Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance. 

Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, Powles T, Warde PR, Daneshmand S, Protheroe A, Tyldesley S, Black PC, Chi K, So AI, Moore MJ, Nichols CR. J Clin Oncol 2014 Aug 18.

 

Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.

Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS, Oldenburg J, Dahl O, Kjellman A, Angelsen A, Cohn-Cedermark G; on behalf of SWENOTECA. Acta Oncol 2014, Sept.

 

Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.

Cohn-Cedermark G, Stahl O, Tandstad T; SWENOTECA.

Andrology. 2014 Oct 1. doi: 10.1111/andr.280. [Epub ahead of print]